Klaus Pantel

Research interests

Publications

• ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

  Annals of Oncology · 2022 · 10.1016/j.annonc.2022.05.520

• Rationale and Design of the Hamburg City Health Study

  European Journal of Epidemiology · 2019 · https://doi.org/10.1007/s10654-019-00577-4

• Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

  BMC Medicine · 2018 · https://doi.org/10.1186/s12916-018-1163-y

• The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

  Critical Reviews in Oncology/Hematology · 2018 · https://doi.org/10.1016/j.critrevonc.2018.12.004

• Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis

  JNCI Journal of the National Cancer Institute · 2018 · https://doi.org/10.1093/jnci/djy152

• Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis

  Carcinogenesis · 2016 · https://doi.org/10.1093/carcin/bgw008

• Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

  Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1483

• Tumour exosome integrins determine organotropic metastasis

  Nature · 2015 · https://doi.org/10.1038/nature15756

• PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis

  Nature Cell Biology · 2014 · https://doi.org/10.1038/ncb3039

• Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

  JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju066

• Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis

  Breast Cancer Research and Treatment · 2014 · https://doi.org/10.1007/s10549-014-2946-2

• Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

  The Lancet Oncology · 2014 · https://doi.org/10.1016/s1470-2045(14)70069-5

• Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma

  Blood · 2013 · https://doi.org/10.1182/blood-2013-03-491431

• Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

  Nature Biotechnology · 2013 · https://doi.org/10.1038/nbt.2576

• Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

  Clinical Cancer Research · 2012 · https://doi.org/10.1158/1078-0432.ccr-12-1407

• Cell-free nucleic acids as biomarkers in cancer patients

  Nature reviews. Cancer · 2011 · https://doi.org/10.1038/nrc3066

• ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy

  Clinical Cancer Research · 2011 · https://doi.org/10.1158/1078-0432.ccr-11-1251

• HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

  Breast Cancer Research and Treatment · 2010 · https://doi.org/10.1007/s10549-010-1163-x

• A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer

  New England Journal of Medicine · 2005 · https://doi.org/10.1056/nejmoa050434

Current projects

No projects listed.